GoldenGolden
Advanced Search
Flagship Pioneering

Flagship Pioneering

U.S-based venture capital firm funding U.S-startups in the life science industry.

Established in 2000, Flagship Pioneering (previously known as Flagship Ventures) is a venture capital firm founded by Noubar Afeyan and Edwin Kania. The firm primarily operates from Cambridge, Massachusetts although it also has an office in Ann Arbor, Michigan. The firm is currently managing a portfolio containing 37 companies and has sold off its shares in 121 companies. The firm’s most recent investment occurred in December 2018 for Indigo Agriculture, a biotechnology company specializing in plant microbiome agricultural services.

Funding

Flagship Pioneering focuses on funding startups that operate in the United States, especially in the Midwest region. The firm prefers to fund companies in the therapeutics, health technologies, life science, sustainability and clean technology business industries. It provides financing for companies at various stages of development, from incubation to growth stage. With its latest funding round raised in September 2017, the firm has managed to collect a total fund of $2.8 billion. During the September 2017 funding round, the firm amassed a total of $618 million in capital.

Timeline

May 10, 2021
Flagship Pioneering announces the launch of its newest company, Laronde, which aims to pioneer new eRNA-based medication, a new type of drug developed at Flagship Labs by general partner Avak Kahvejian.
May 27, 2020
Flagship Pioneering launches new agtech company to manage insect populations.

Funding Rounds Participated In

Funding rounds

Associated investment funds

Invested in

People

Name
Role
LinkedIn

Adam J Koch

Employee

Avak Kahvejian

Employee

Bill Koteff

Employee

Brett Morrison

Employee

Brian Fiske

Employee

Bruce Miller

Investor

Chris Varma

Employee

Chuck Carelli

Chief Financial Officer

Chuck Eesley

Employee

David Berry

Employee

Deepak Jagannathan

Employee

Devesh Khanal

Employee

Edwin Kania

Co-Founder/Managing Partner

Emil Mamedov

Employee

Grace Brueckner

Employee

Harry Wilcox

Chief Operating Officer

Jacqueline Heard

Employee

Jaime Mateus

Employee

Jameson Rogers

Employee

Jason Patrick Schrum

Employee

Jernej Godec

Employee

Jerry Gupta

Employee

John Ballew

Employee

Kunle Demuren

Employee

Maneesh Gujrati

Employee

Page 1 of 2

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Agios

Alinea

Alvine Pharmaceutical

Avedro

Axcella

Bind Biosciences

News

Title
Author
Date
Publisher
Description
Conor Hale
September 9, 2021
FierceBiotech
After landing a job at the life sciences incubator Flagship Pioneering earlier this summer, former FDA Commissioner Stephen Hahn will now serve a stint as the interim medical chief at one of the venture firm's portfolio companies, focused on blood collection and COVID-19 diagnostics.
FinSMEs
August 30, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Alex Keown
June 15, 2021
BioSpace
The new division would benefit from Hahn's experience and help steer the company's Preemptive Medicine and Health Security initiative.
BioSpace
June 15, 2021
BioSpace
Tessera Therapeutics announced today the appointment of Elliott Sigal, M.D., Ph.D. and Mary Rozenman, Ph.D. to the company's Board of Directors.
Kyle LaHucik
June 14, 2021
FierceBiotech
Ex-FDA Commissioner Stephen Hahn, M.D., is joining Moderna incubator Flagship Pioneering six months after granting the company an emergency use authorization for its COVID-19 vaccine.
Flagship Pioneering
June 14, 2021
www.prnewswire.com:443
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that Stephen Hahn, M.D. will help lead its Preemptive Medicine and...
Kyle LaHucik
June 14, 2021
FierceBiotech
Flagship Pioneering wanted a little more heft behind its latest voyage. The biotech innovator and venture firm increased its April 2020 fund from $1.1 billion to a total of $3.37 billion on Monday to drive a preemptive medicine focus.
Crunchbase News
June 14, 2021
Crunchbase News
Crunchbase News' top picks of the news to stay current in the VC and startup world.
Natasha Mascarenhas
June 14, 2021
TechCrunch
Hello and welcome back to Equity, TechCrunch's venture capital-focused podcast where we unpack the numbers behind the headlines. This is Equity Monday, our morning coffee chat with you that is all about the weekend, what to expect this week, and some funding rounds you may have missed. I'm subbing in for Alex Wilhelm today, who is [...]
Alex Keown
June 14, 2021
BioSpace
Flagship Pioneering announced a massive cash infusion to support the development and launch of new companies aiming at various diseases and global health threats.
FinSMEs
June 14, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Flagship Pioneering
June 14, 2021
www.prnewswire.com:443
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced a significant expansion of its capital base to support founding and...
Alex Keown
June 4, 2021
BioSpace
Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.
Alex Keown
May 26, 2021
BioSpace
BioSpace looks at five of the top investor companies that support life sciences companies across the industry.
FinSMEs
May 12, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Amirah Al Idrus
May 12, 2021
FierceBiotech
After two years as Gossamer Bio's chief scientist, Luisa Salter-Cid, Ph.D. has landed at Flagship Pioneering, where she will spearhead the development of new medicines based on technology from the firm's portfolio companies. She joins fellow Bristol Myers Squibb veteran Paul Biondi, now an executive partner at Flagship and president of its Pioneering Medicines division.
Alex Keown
May 10, 2021
BioSpace
Over the past year, the world at large has become more familiar with mRNA technology thanks to vaccines developed against COVID-19. Now the world will be introduced to a new type of RNA-based medicine called Endless RNA, or eRNA for short.
Flagship Ventures
May 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- Flagship Pioneering today unveiled Laronde, a platform company developing Endless RNATM (eRNA), a novel, engineered form of RNA that can be...
Reuters
April 23, 2021
news.yahoo.com
Medicago is conducting a late-stage study of its experimental COVID-19 vaccine combined with a booster from GlaxoSmithKline. The company said it would...
April 13, 2021
BioSpace
Repertoire Immune Medicines Secures $189M Financing to Advance Pipeline Programs and Discovery Platform Directed at Cellular Immune Targets - read this article along with other careers information, tips and advice on BioSpace
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.